Related Experiment Video
Updated: Aug 8, 2026
06:22
Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)
Published on: April 7, 2021
Surfactant protein D in human lung diseases
1Department of Pediatric Pneumology, Hauner Children's Hospital, Ludwig-Maximilians-University, Munich, Germany.
European Journal of Clinical Investigation
|May 11, 2006
Summary
Surfactant protein D (SP-D) is crucial for lung defense and regulating allergies. Lower SP-D levels in lung diseases suggest its potential as a therapeutic agent and biomarker.
Area of Science:
- Pulmonary immunology
- Innate immunity
- Respiratory medicine
Background:
- The lungs face constant exposure to inhaled environmental factors like pollutants and microbes.
- Maintaining a balance between pathogen defense and preventing inflammation to harmless particles is vital for lung health.
- Innate immune proteins, specifically surfactant proteins in the bronchoalveolar space, are key to this balance.
Purpose of the Study:
- To review the multifaceted role of surfactant protein D (SP-D) in pulmonary host defense and allergic responses.
- To explore the clinical significance of SP-D levels in various human lung diseases.
- To highlight the translational potential of SP-D from laboratory findings to therapeutic applications.
Main Methods:
- Literature review of in vitro studies and clinical data on surfactant protein D.
- Analysis of the role of SP-D in host defense mechanisms against pathogens and allergens.
- Examination of SP-D levels as biomarkers in interstitial lung diseases and other pulmonary conditions.
Main Results:
- Surfactant protein D (SP-D) is essential for pulmonary host defense and modulating allergic reactions.
- Decreased levels of SP-D are observed in several human lung diseases, including cystic fibrosis and emphysema.
- SP-D serum levels show potential as markers for disease activity in interstitial lung diseases.
Conclusions:
- Surfactant protein D plays a critical role in maintaining lung homeostasis and immune function.
- Recombinant SP-D is a promising therapeutic candidate for lung diseases associated with SP-D deficiency.
- SP-D levels serve as valuable indicators for diagnosing and monitoring lung diseases.
Related Concept Videos
01:05Breathing
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
01:17Pulmonary Cycle: Exhalation
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:19Factors Affecting Pulmonary Ventilation
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:18Pulmonary Edema II: Pathophysiology
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...